![Immunofluorescence staining of MEFs with anti-RAP1 [RAP1 4C8/1] antibody.](https://cancertools.org/wp-content/uploads/83266897-5bc1-4229-9287-8e41d57ab71f.jpg)
Cat. #151285
Anti-RAP1 [RAP1 4C8/1]
Cat. #: 151285
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: RAP1
Class: Monoclonal
Application: ELISA ; FACS ; IHC ; IF ; WB
Reactivity: Human ; Mouse
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Stephen West
Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-RAP1 [RAP1 4C8/1]
- Research fields: Cell biology;Genetics
- Clone: RAP1 4C8/1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human ; Mouse
- Host: Mouse
- Application: ELISA ; FACS ; IHC ; IF ; WB
- Description: Rap1 is a telomeric protein. Rap1 contributes to both telomere length regulation and telomere silencing.
- Immunogen: Human Rap1
- Isotype: IgG2b
- Myeloma used: Sp2/0-Ag14
- Recommended controls: HeLa cell and mouse testis extracts.
Target Details
- Target: RAP1
- Tissue cell line specificity: HeLa cell and mouse testis extracts.
- Target background: Rap1 is a telomeric protein. Rap1 contributes to both telomere length regulation and telomere silencing.
Applications
- Application: ELISA ; FACS ; IHC ; IF ; WB
Handling
- Format: Liquid
- Concentration: 0.43 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Wang et al. 2015. Circulation. 132(20):1909-19. PMID: 26416809.
- Bombarde et al. 2010. EMBO J. 29(9):1573-84. PMID: 20407424.
- TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends.
